Home  /  What We Solve  /  Outdated pharma content and slide decks

Your materials are outdated. Your audience noticed.

Your presentations may still be strategically sound, but slide decks require ongoing updates as new evidence emerges. The same deck used repeatedly loses engagement. Internal teams rarely have time to refresh.

Medical Affairs Brand & Launch Mature Brand
Why this happens

Evidence evolves. Content doesn’t update itself.

Medical presentations have a shelf life. New congress data, updated guidelines, label changes, and competitor publications all require content updates. But most teams treat content creation as a one-time project.

The result: materials that were excellent at launch become progressively outdated. MSLs present 2-year-old data. The brand deck still references pre-launch trials. Payer materials haven’t integrated the latest RWE.

Audiences notice. KOLs see the same slides they’ve seen before. Internal teams lose confidence in stale materials. The content still works strategically — but it doesn’t engage.

“I’ve been using the same 40-slide deck for 18 months. The KOLs know it by heart. I need something fresh but nobody has time.”
— Marketing Director EMEA, Neurology
Sound familiar?

Typical situations we hear

01
Core deck hasn’t changed since launch
The scientific presentation was created 2 years ago. New Phase IV data and guideline updates haven’t been integrated.
02
Same deck, declining engagement
MSLs report KOLs are less engaged. The content is accurate but familiar. No new data, no fresh visuals.
03
New evidence available, no capacity
A landmark publication supports your positioning. The data should be in every deck — but nobody has bandwidth.
04
Compliance risk from outdated references
Some references have been superseded. MLR review flags issues, triggering revision cycles.
What breaks without intervention

The cost of doing nothing

Declining KOL engagement
Experts lose interest in presentations they’ve seen before. Scientific discussions become routine.
Missed evidence integration
New supportive data isn’t incorporated. The strongest evidence for your product goes unused.
Compliance exposure
Outdated references and superseded data create regulatory risk.
How MAG solves it

From stale content to evergreen materials

1
Content audit & evidence scan
We review existing materials and cross-reference against the current evidence landscape.
2
Update prioritization
We triage updates by strategic impact: which materials reach the most stakeholders, which gaps are most critical.
3
Evidence integration
We incorporate new data — congress results, publications, guidelines, RWE — while maintaining narrative consistency.
4
Visual refresh
Beyond data updates, we refresh the visual presentation — updated visualizations, modern layouts, engaging formats.
5
Ongoing refresh cadence
We establish a quarterly or post-congress update cycle — ensuring materials stay current.
What you get

Typical deliverables

Updated slide deck
Evidence refresh report
New data integration inserts
Visual redesign package
Reference update log
Content currency assessment
Quarterly update plan
Frequently asked

Common questions

How often should we update our materials?
Quarterly evidence review with immediate updates for high-impact publications, congress data, and guideline changes.
Can you update materials across multiple markets simultaneously?
Yes. We use a hub-and-spoke model — updating the core deck first, then cascading to market-specific adaptations.
Do you handle the visual redesign too?
Yes. Our team includes medical content experts and professional designers.
How do you track which materials need updating?
We set up monitoring linked to your materials — Evidence Scanner™ flags relevant new publications, triggering update recommendations.
Can you work within our existing templates?
Absolutely. We work within your brand guidelines. If templates need refreshing, we can propose updated designs.
Still have questions about content refresh?
Book a 20-minute scoping call. We’ll review your situation and suggest the fastest path forward.
Book a scoping call → Browse all services
Materials getting
stale?

Send us your current deck — we’ll deliver a content audit and update plan within one week.

Evidence Scanner
Evidence ScannerTM
AI infrastructure

AI-powered.
Expert-validated.

We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.

Research
Structured PubMed queries with narrative or table outputs
Monitoring
Weekly literature digests by drug, target, or topic
AI-Enhanced EDC
Advisory board transcription + structured AI summary
Fact-Checker
Claim verification against your source documents
AI accelerates. Our experts validate.
Every output goes through expert medical review before it reaches your team. AI handles structure and speed — we handle scientific judgement and MLR readiness.
Evidence Scanner·Research module
// Query: PCSK9 inhibitor outcomes data update 2024
search("PCSK9 inhibitor lipid-lowering update", {
  years: [2024, 2025],
  output: "structured_table"
})
// 760 records → 21 relevant
Processing 760 records...
Evidence Update
New since last refresh: FOURIER-OLE 8-year data (JACC 2024) — evolocumab sustained LDL-C reduction, 15% relative MACE reduction maintained. Should update slides 12, 18, and 24...